Connect with us

TechCrunch

FindAir is a smart inhaler

FindAir is digitizing asthma therapy with smart inhaler technology. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech…

Published

on

FindAir is digitizing asthma therapy with smart inhaler technology.

The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education.

TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

Continue Reading
Advertisement
9 Comments

9 Comments

  1. Abhishek Rao Chimbili

    October 27, 2019 at 4:51 pm

    That is the most useless thing I’ve ever seen.

  2. Brandon S.

    October 27, 2019 at 4:52 pm

    You are supposed to use a spacer. The inhaler alone is not good. Not to mention there are some inhalers that already track the number of uses. This is pointless.

  3. Greg Nulik

    October 27, 2019 at 7:21 pm

    Hope the sensor supports a full dosage.

  4. polyannamoonbeam

    October 27, 2019 at 10:39 pm

    Not enough info …sensor tells you what your trigger was…? How? Blood prick analysis? Heartrate? Allergen analysis? Doctors are now instructed to ration patients to one Ventolin a month, two if you argue at length. There is no science to back up patients self diagnosed need for more, doctors differ on what is sufficient, how to measure severity and are often punitive/ biased against smokers. Many patients become resistant to their Ventolyn due to misuse, long term use.. tracking usage doesnt tell you whether patient needed to use more or less puffs for each event or just misused due to poor technique….severe attacks are not managed by Ventolin. Steroids,adrenalin, intravenous meds, full mask vaporised meds- we use all in winter for son.

  5. Pinitrius

    October 27, 2019 at 11:34 pm

    Being an allergist I was interested to see what this was about… But no! It gives some information about patient adherence to the treatment but as with many products/service it is trying to force a subscription down patients throat without providing real long term value! And the product itself is rendered useless after 12 months due to the non-removable battery!

    To me it is just a gimmick the way they chose to make it and charge for it! Sorry…

  6. TechPimp

    October 28, 2019 at 1:51 am

    I didn’t understand what the heck it does?

  7. Gezaei Teklay

    October 28, 2019 at 2:09 am

    I hope it is helpful for asthma

  8. Arthur

    October 28, 2019 at 9:12 am

    So it counts how many times you use an inhaler a day and displays it on an app?

  9. takeonparis

    October 29, 2019 at 12:15 am

    This is the dumbest interview I’ve ever seen. He doesn’t even bother to ask: “So what does your product DO?” Like what in the actual hell…

Leave a Reply

Your email address will not be published. Required fields are marked *

Science & Technology

Tesla runs into trouble with Cybertruck recall l TechCrunch Minute

Tesla is recalling every Cybertruck shipped due to an issue with the accelerator pedals that causes them to get stuck in the footwell and putting the driver at risk. Tesla is now retooling or replacing all accelerator pedals on Cybertrucks, in what has been the second recall so far for the vehicle. The announcement came…

Published

on

Tesla is recalling every Cybertruck shipped due to an issue with the accelerator pedals that causes them to get stuck in the footwell and putting the driver at risk. Tesla is now retooling or replacing all accelerator pedals on Cybertrucks, in what has been the second recall so far for the vehicle. The announcement came at the end of a pretty tumultuous week for Tesla, with layoffs, executive exits. And this week, we’ll see what their Q1 earnings look like. TechCrunch’s Alex Wilhelm breaks down what the recall means for the EV manufacturer and if more bad news could be coming down the pike.

Subscribe for more on YouTube:

Follow TechCrunch on Instagram:
TikTok:
X:
Facebook:

Read more:

Continue Reading

People & Blogs

Mobile ALOHA | Zipeng Fu, Tony Z. Zhao, Chelsea Finn | TechCrunch

Mobile ALOHA is a low-cost and whole-body teleoperation system for data collection from PhD students at Stanford University

Published

on

Mobile ALOHA is a low-cost and whole-body teleoperation system for data collection from PhD students at Stanford University

Continue Reading

Science & Technology

Meta claims Llama 3 is the most advanced open source AI yet l TechCrunch Minute

Meta is advancing its AI, and putting AI products in more and more places across Facebook and Instagram. Meta has added two more models into their generative AI family: Llama 3 8B and Llama 3 70B. These generative AI models are notable because they are trained on a massive data set which should make them…

Published

on

Meta is advancing its AI, and putting AI products in more and more places across Facebook and Instagram. Meta has added two more models into their generative AI family: Llama 3 8B and Llama 3 70B. These generative AI models are notable because they are trained on a massive data set which should make them smarter, quicker, and all around better for the user. At least that is what Meta’s messaging is pushing. TechCrunch’s Alex Wilhelm discusses how Llama 3 stands up against the competition and where Meta users may see them put to use.

Subscribe for more on YouTube:

Follow TechCrunch on Instagram:
TikTok:
X:
Facebook:

Read more:

Continue Reading

Trending